- Home
- LAB vs GMRE Comparison
LAB vs GMRE Comparison
Compare LAB & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- GMRE
- Stock Information
- Founded
- LAB 1999
- GMRE 2011
- Country
- LAB United States
- GMRE United States
- Employees
- LAB N/A
- GMRE N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- GMRE Real Estate Investment Trusts
- Sector
- LAB Industrials
- GMRE Real Estate
- Exchange
- LAB Nasdaq
- GMRE Nasdaq
- Market Cap
- LAB 504.2M
- GMRE 428.4M
- IPO Year
- LAB 2011
- GMRE N/A
- Fundamental
- Price
- LAB $1.27
- GMRE $30.93
- Analyst Decision
- LAB Buy
- GMRE Buy
- Analyst Count
- LAB 2
- GMRE 3
- Target Price
- LAB $2.50
- GMRE $47.92
- AVG Volume (30 Days)
- LAB 1.6M
- GMRE 203.3K
- Earning Date
- LAB 11-04-2025
- GMRE 11-04-2025
- Dividend Yield
- LAB N/A
- GMRE 9.64%
- EPS Growth
- LAB N/A
- GMRE N/A
- EPS
- LAB N/A
- GMRE 0.34
- Revenue
- LAB $172,271,000.00
- GMRE $141,896,000.00
- Revenue This Year
- LAB N/A
- GMRE $8.69
- Revenue Next Year
- LAB N/A
- GMRE $5.10
- P/E Ratio
- LAB N/A
- GMRE $92.75
- Revenue Growth
- LAB 76.33
- GMRE 2.95
- 52 Week Low
- LAB $0.92
- GMRE $30.09
- 52 Week High
- LAB $2.32
- GMRE $47.05
- Technical
- Relative Strength Index (RSI)
- LAB 45.10
- GMRE 63.31
- Support Level
- LAB $1.24
- GMRE $31.32
- Resistance Level
- LAB $1.44
- GMRE $32.61
- Average True Range (ATR)
- LAB 0.08
- GMRE 0.75
- MACD
- LAB -0.00
- GMRE -0.87
- Stochastic Oscillator
- LAB 10.32
- GMRE 33.84
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.